NCC to build 185 rental apartments in Lund
Reading Time: 2 minutes NCC, on behalf of Tetra Laval Real Estate AB, is to build 185 apartments in the Västerbro district in central Lund. The project is a turnkey contract and the order value is approximately SEK 330 million. Vision image of the Smörkärnan
MBK Partners and Young Poong Refute Korea Zinc’s Baseless Claims
Reading Time: 2 minutes Seoul, South Korea: MBK Partners has clarified its position on a matter involving Korea Zinc, stating that the company is making claims that are far from reality. The matter dates back to May 2022, when a person known to be close
Now Is the Time To Host Events in Japan, With the Yen at a Low! Global Produce Launches Full-Scale Production of “Event Hosting in Japan” for Overseas Companies
Reading Time: 2 minutes TOKYO, Japan: Global Produce Co., Ltd. (Head Office: Shibuya Ward, Tokyo; CEO: Masaki Kouhata; hereinafter referred to as “Global Produce”), a company specializing in event production, is pleased to announce the full-scale launch of its production services for overseas companies looking
Earnings Release – Royal Bank of Canada
Reading Time: < 1 minute Regulatory Announcement December 4, 2024 Fourth Quarter 2024 Earnings Release The Fourth Quarter 2024 Earnings Release has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism To view the full document, please paste the
SyntheticMR AB (publ) appoints Vedran Beglerbegovic as Acting CEO for SyntheticMR
Reading Time: < 1 minute The board of SyntheticMR AB (publ) has today decided to appoint Vedran Beglerbegovic as Acting CEO with immediate effect, due to the current CEO, Ulrik Harrysson, being on sick leave indefinitely. Vedran Beglerbegovic, who currently holds the position of COO
Leqembi® approved in Mexico – BioArctic
Reading Time: 4 minutes Stockholm, Sweden, December 5, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved Leqembi (lecanemab) for the treatment of early Alzheimer’s disease (AD)[1].
#24-417 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 04.12.2024
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 04.12.2024 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 04.12.2024 Date 04.12.2024 Exchange transaction Buy Share class ALEX Amount 69 Average price/share 8.5500 EUR Highest
RESULTS OF PROPOSED PLACING OF SHARES IN SYNSAM AB (PUBL)
Reading Time: 6 minutes Not for publication, distribution or release directly or indirectly, in whole or in part, in or into the United States of America, Australia, Canada, Hong Kong, New Zealand, Japan, Switzerland or South Africa or in any other jurisdiction in which offers
OBSERVE MEDICAL ASA: Preliminary results of the subsequent offering
Reading Time: 7 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT